Abstract:The purpose of the study presented in this paper has been to examine the possibility of the synthesis of a new nanoparticulate system for controlled and systemic drug delivery with double effect. In the first step, a drug is released from bioresorbable polymer; in the second stage, after resorption of the polymer, non-bioresorbable calcium phosphate remains the chief part of the particle and takes the role of a filler, filling a bone defect. The obtained tigecycline-loaded calcium-phosphate(CP)/poly(DL-lactide… Show more
“…The average size was from 65-95 nm. This composited nanoparticles proved to be an adequate system for local and controlled drug release [50]. Another group of novel composite nanoparticles combining glycidyl methacrylate derivatised dextrans with gelatine was reported.…”
“…The average size was from 65-95 nm. This composited nanoparticles proved to be an adequate system for local and controlled drug release [50]. Another group of novel composite nanoparticles combining glycidyl methacrylate derivatised dextrans with gelatine was reported.…”
“…Upravo ovakav koncept je primenjen u dizajniranju nHAP-a za lokalnu dostavu tigeciklina a u cilju lečenja osteomijelitisa [63,64]. Kompozitni biomaterijal na bazi HAp/PLLA [65], sa visoko kristalnom HAp fazom, je sintetizovan u dva koraka.…”
Section: Sinteza I Dizajniranje Multifunkci-unclassified
“…66 Apart from PLGA-related nanomaterials, other targeted delivery systems for bone diseases were reported. For example, Ignjatović et al 67 reported a double delivery system where a new nanoparticulate system for controlled and systemic drug delivery with double effect was reported. In their design, the drug is released from the bioresorbable polymer first; then, after resorption of the polymer, nonbioresorbable calcium phosphate remains the chief part of the particle and takes the role of a filler, filling a bone defect.…”
Section: Infection and Inflammatory Bone Diseasesmentioning
Nanotechnology is a vigorous research area and one of its important applications is in biomedical sciences. Among biomedical applications, targeted drug delivery is one of the most extensively studied subjects. Nanostructured particles and scaffolds have been widely studied for increasing treatment efficacy and specificity of present treatment approaches. Similarly, this technique has been used for treating bone diseases including bone regeneration. In this review, we have summarized and highlighted the recent advancement of nanostructured particles and scaffolds for the treatment of cancer bone metastasis, osteosarcoma, bone infections and inflammatory diseases, osteoarthritis, as well as for bone regeneration. Nanoparticles used to deliver deoxyribonucleic acid and ribonucleic acid molecules to specific bone sites for gene therapies are also included. The investigation of the implications of nanoparticles in bone diseases have just begun, and has already shown some promising potential. Further studies have to be conducted, aimed specifically at assessing targeted delivery and bioactive scaffolds to further improve their efficacy before they can be used clinically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.